Dengue - A Pipeline Analysis Report

Published: Sep 2018 Pages: 80 SKU: IRTNTR23854

Overview of the drug development for Dengue

Dengue is a mosquito-borne tropical disease caused by the dengue virus which is a single positive-stranded RNA virus. Aedes mosquito is the major cause for the transmission of Dengue. Dengue is one of the most common diseases which is prevalent in tropical and subtropical regions. Aedes mosquitos can breed in optimal rainfall environment and can carry the disease. Dengue is prevalent in 100 countries in Asia, the Pacific, the Americas, Africa, and the Caribbean. It has been observed that most of the dengue cases were reported in 48 continental states. Based on the CDC reports, the WHO estimated that 50-100 million infections occur yearly, which consists of 50,0000 DHF cases and 22,000 deaths, mostly among children.

According to this pipeline analysis report, most of the drug molecules in the pipeline are being developed for Dengue. Our market research analysts have also identified that most of these molecules are in the pre-clinical development stage and a considerable number of molecules have been discontinued from development.

Want a bigger picture? Try a FREE sample of this report now!

Drug development for Dengue market research report: Companies covered

This pipeline analysis report provides a detailed analysis of the companies that are involved in the development of drug molecules for the treatment of Dengue. In addition to providing information on the various stages of molecules developed by companies for different indications, this pipeline analysis report also provides information about the gene therapy molecules discontinued by companies.

Some of the companies covered in this pipeline analysis report are

  • Abivax
  • BioNet-Asia
  • Codagenix

Therapeutic assessment of drug development for Dengue by route of administration

  • Oral
  • Subcutaneous
  • Intramuscular

The oral route of administration involves the application of drugs directly through the mouth cavity.

Therapeutic assessment of the drug development for Dengue by therapy

  • Monotherapy
  • Monotherapy/combination therapy
  • Combination therapy

According to this pipeline analysis report, most of the molecules that are currently in the drug development for Dengue are being developed as monotherapy drugs. In this technique, a single drug is used to treat a particular disorder.

Key questions answered in the report include

  • What are the drug molecules in the various development stages for Dengue?
  • What are the companies that are currently involved in the drug development for Dengue?
  • Insight into discontinued/inactive molecules with appropriate reasoning?
  • What are the major regulatory authorities approving drugs in various regions?
  • Detailed profiling of each active molecule

 

Technavio also offers customization on reports based on specific client requirement.

 

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

PART 05: MAJOR REGULATORY AUTHORITIES

  • US
  • Europe
  • China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

  • Discovery stage molecules
  • Pre-clinical stage molecules
  • Inactive and discontinued molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)

PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)

PART 11: THERAPEUTIC ASSESSMENT BY TARGET

PART 12: KEY COMPANIES

  • Active companies: Category and parameters

PART 13: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis